Revolutionizing Hormone Testing: Level Zero Health's $6.9M Leap Forward
Level Zero Health raises $6.9M to develop a continuous hormone monitor, promising to revolutionize personalized healthcare.
Matilda
Revolutionizing Hormone Testing: Level Zero Health's $6.9M Leap Forward
Imagine a world where managing your hormone health is as simple as wearing a patch. No more invasive blood draws, no more inconvenient clinic visits. This is the future Level Zero Health, a female-founded medical device startup, is striving to create. Their recent successful pre-seed funding round, raking in an impressive $6.9 million, underscores the immense potential of their vision: a continuous hormone monitoring device. This substantial investment, despite the company being just over a year old, speaks volumes about the confidence investors have in Level Zero Health's innovative approach. The oversubscribed round, led by European VC redalpine, with participation from HAX (SOSV), Entrepreneur First (EF), and industry experts, signals a strong belief in the company's ability to disrupt the current paradigm of hormone testing. Currently, hormone testing often involves invasive and time-consuming blood draws, providing only a snapshot of hormone levels at a specific moment. …
